Does Rallies show Form 4 insider transactions for GMED?

Yes. Rallies tracks GMED insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GMED research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GMED. It does not provide personalized investment advice.

GMED (GLOBUS MEDICAL INC) Stock Analysis - Insider Trades

GLOBUS MEDICAL INC (GMED) is a publicly traded Healthcare sector company. As of May 20, 2026, GMED trades at $84.53 with a market cap of $10.71B and a P/E ratio of 110.28. GMED moved +5.14% today. Year to date, GMED is -7.12%; over the trailing twelve months it is +36.41%. Its 52-week range spans $51.79 to $101.40. Analyst consensus is strong buy with an average price target of $110.90. Rallies surfaces GMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GMED stock inside the company?

Recent GMED insider activity includes Huller Kelly sold 20.00K, Huller Kelly sold 10.00K, Kline Kyle sold 3.59K, Norwalk Leslie V sold 2.00K, and Norwalk Leslie V sold 4.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GMED Key Metrics

Key financial metrics for GMED
Metric	Value
Price	$84.53
Market Cap	$10.71B
P/E Ratio	110.28
EPS	$0.76
Dividend Yield	0.00%
52-Week High	$101.40
52-Week Low	$51.79
Volume	2.15M
Avg Volume	0
Revenue (TTM)	$2.52B
Net Income	$102.98M
Gross Margin	58.90%

Recent GMED Insider Trades

Huller Kelly sold 20.00K (~$1.89M) on Feb 25, 2026.
Huller Kelly sold 10.00K (~$876.70K) on Feb 12, 2026.
Kline Kyle sold 3.59K (~$363.35K) on Jan 8, 2026.
Norwalk Leslie V sold 2.00K (~$202.20K) on Jan 8, 2026.
Norwalk Leslie V sold 4.00K (~$355.40K) on Dec 12, 2025.

Latest GMED News

Globus Medical Q1 Sales Soar 27% to $759.9M, EPS Up 66.6% — May 7, 2026
Globus Medical jumps ahead of May 7 Q1 earnings catalyst and growth expectations — Apr 30, 2026
Globus Medical slips as FY2026 EPS estimates get trimmed ahead of May earnings — Apr 29, 2026
Globus Medical slides 3% as traders de-risk ahead of May 7 earnings — Apr 28, 2026
Globus Medical slips as traders de-risk ahead of May 7 Q1 earnings report — Apr 21, 2026

GMED Analyst Consensus

12 analysts cover GMED: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.90.

Common questions about GMED

Who is trading GMED stock inside the company?: Recent GMED insider activity includes Huller Kelly sold 20.00K, Huller Kelly sold 10.00K, Kline Kyle sold 3.59K, Norwalk Leslie V sold 2.00K, and Norwalk Leslie V sold 4.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GMED?: Yes. Rallies tracks GMED insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GMED research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GMED. It does not provide personalized investment advice.